It'll Help on the Balance Sheet, Too | GenomeWeb

How's this for belt-tightening? The Wall Street Journal reports that GlaxoSmithKline has announced it will "no longer use corporate funds for political contributions as part of an effort to improve openness in its business," according to the article. The company donated more than $585,000 in the US this year. (The company adopted this same policy in Europe in 2001.) No word, though, on whether that money will be redirected to R&D.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.